Pharmaceutical

Alpha Tau to Participate in Five September Investor Conferences

JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…

4 months ago

Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences

THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will…

4 months ago

The Baker Company Enhances Scientific Engagement and Internal Efficiency With Bioz Badges and a Bioz Content Hub

PALO ALTO, CALIFORNIA / ACCESS Newswire / August 27, 2025 / Bioz, Inc., a cutting-edge AI platform that transforms research…

4 months ago

Cosmo Receives Positive CHMP Opinion for Winlevi(R) for Treatment of Acne in Adults and Adolescents, Following Successful Re-Examination

Dublin, Ireland--(Newsfile Corp. - August 27, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and…

4 months ago

CV Sciences Launches Ignite: A Men’s Performance Formula for Vitality, Recovery, Libido & Focus

Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp,…

4 months ago

Where Is The Catholic Marijuana Vote For The Patients?

Nearly 50 groups, including CatholicVote, are lobbying Trump to keep marijuana Schedule I - but where is that same passion…

4 months ago

Health Canada Approves MedMira’s Reveal(R) Rapid TP Test – Urgent New Tool In The Battle Against Syphilis

HALIFAX, NOVA SCOTIA / ACCESS Newswire / August 26, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has…

4 months ago

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025

NEWARK, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that…

4 months ago

Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025

HAMILTON, BERMUDA / ACCESS Newswire / August 26, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company…

4 months ago

Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows

Physicians, researchers, and partner institutions across Europe aim to deliver innovative, personalized therapies more quickly Development project focused on a…

4 months ago